IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q2 2023 Holdings

Filed 2023-07-19 | 6 holdings | $356.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$123.6M19,963,15734.6%
Vaxcyte Inc(PCVX)COM92243G108$65.7M1,315,43518.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$53.9M3,760,86915.1%
Merus N VCOMN5749R100$42.1M1,600,00011.8%
Aura Biosciences Inc(AURA)COM05153U107$37.5M3,039,89210.5%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$34.1M2,869,5659.6%